RCAG
SNY icon

Rehmann Capital Advisory Group’s Sanofi SNY Stock Holding History

Rehmann Capital Advisory Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Sell
6,381
-7,659
-55% -$357K 0.02% 542
2025
Q4 		$680K Buy
14,040
+1,083
+8% +$53.7K 0.04% 325
2025
Q3 		$611K Sell
12,957
-597
-4% -$28.8K 0.03% 339
2025
Q2 		$655K Sell
13,554
-846
-6% -$43.2K 0.04% 299
2025
Q1 		$799K Buy
14,400
+709
+5% +$38.4K 0.05% 260
2024
Q4 		$660K Sell
13,691
-908
-6% -$46.2K 0.04% 286
2024
Q3 		$844K Buy
14,599
+1,213
+9% +$65.5K 0.06% 237
2024
Q2 		$649K Buy
13,386
+2,225
+20% +$107K 0.05% 275
2024
Q1 		$542K Sell
11,161
-75
-0.7% -$3.66K 0.04% 301
2023
Q4 		$559K Sell
11,236
-557
-5% -$27.2K 0.05% 288
2023
Q3 		$633K Buy
11,793
+1,275
+12% +$68K 0.06% 254
2023
Q2 		$567K Buy
10,518
+1,281
+14% +$68.9K 0.05% 284
2023
Q1 		$503K Buy
9,237
+3,001
+48% +$146K 0.05% 301
2022
Q4 		$302K Sell
6,236
-1,180
-16% -$51.8K 0.03% 412
2022
Q3 		$282K Buy
+7,416
New +$330K 0.03% 393
2019
Q3 		$341K Sell
7,361
-665
-8% -$28.7K 0.04% 226
2019
Q2 		$347K Buy
8,026
+952
+13% +$40.5K 0.04% 313
2019
Q1 		$313K Sell
7,074
-1,312
-16% -$56.2K 0.04% 317
2018
Q4 		$364K Buy
8,386
+2,436
+41% +$107K 0.05% 171
2018
Q3 		$266K Buy
5,950
+766
+15% +$32.7K 0.04% 333
2018
Q2 		$207K Sell
5,184
-1,071
-17% -$42.2K 0.03% 365
2018
Q1 		$251K Buy
6,255
+131
+2% +$5.45K 0.04% 318
2017
Q4 		$263K Sell
6,124
-1,113
-15% -$51.3K 0.04% 307
2017
Q3 		$360K Buy
7,237
+2
+0% +$97 0.06% 231
2017
Q2 		$347K Buy
7,235
+47
+0.7% +$2.25K 0.07% 219
2017
Q1 		$325K Buy
7,188
+698
+11% +$29.6K 0.05% 253
2016
Q4 		$262K Buy
6,490
+981
+18% +$38.7K 0.05% 299
2016
Q3 		$210K Sell
5,509
-62
-1% -$2.49K 0.04% 343
2016
Q2 		$233K Buy
5,571
+26
+0.5% +$1.07K 0.04% 313
2016
Q1 		$223K Sell
5,545
-674
-11% -$27.1K 0.04% 304
2015
Q4 		$265K Sell
6,219
-51
-0.8% -$2.35K 0.06% 259
2015
Q3 		$298K Buy
6,270
+37
+0.6% +$1.88K 0.07% 226
2015
Q2 		$309K Sell
6,233
-538
-8% -$27.3K 0.07% 221
2015
Q1 		$335K Buy
6,771
+90
+1% +$4.3K 0.08% 213
2014
Q4 		$305K Sell
6,681
-1,111
-14% -$53.9K 0.07% 235
2014
Q3 		$440K Sell
7,792
-277
-3% -$14.9K 0.1% 166
2014
Q2 		$429K Buy
8,069
+124
+2% +$6.58K 0.1% 166
2014
Q1 		$415K Buy
+7,945
New +$402K 0.11% 156
2013
Q3 		– Sell
-4,373
Closed -$225K – 294
2013
Q2 		$225K Buy
+4,373
New +$233K 0.08% 218

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rehmann Capital Advisory Group's SNY Position: Q1 2026 in Review

Rehmann Capital Advisory Group reduced its Sanofi (SNY) stake by 55% in Q1 2026, selling an estimated $357K and leaving 6,381 shares worth $307K. The position accounts for 0.02% of the portfolio, ranked #542.

Rehmann Capital Advisory Group first reported a position in SNY in Q2 2013 and has held it in 39 quarters since. The position peaked at $844K in Q3 2024. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Rehmann Capital Advisory Group held 6,381 shares of Sanofi worth $307K as of Q1 2026.
  • Rehmann Capital Advisory Group sold 7,659 Sanofi shares in Q1 2026, an estimated $357K.
  • Sanofi made up 0.02% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #542 holding.
  • Rehmann Capital Advisory Group first reported a position in Sanofi in Q2 2013 and has held it in 39 quarters since.
  • Rehmann Capital Advisory Group's Sanofi position peaked at $844K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.